Global Antibody Drug Conjugates Market: Technology and Innovation
The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering a strong CAGR of 21.3% during 2023–2031. Rising demand for targeted cancer therapies and rapid advancements in biotechnology are driving the adoption of ADC treatments across global healthcare systems.
Growing investments in...
0 Yorum
0 Paylar
English